Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.37 |
| ▸ | LPL | P06858 | 5/20 | 0.36 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.33 |
| ▸ | TACR2 | P21452 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL121471 | 0.77 | LPL (0.56) | PTGS2LPLLIPGCYP3A4ESR1 | |
| SCHEMBL15072065 | 0.77 | LPL (0.56) | PTGS2LPLLIPGCYP3A4ESR1 | |
| SCHEMBL31516134 | 0.77 | LPL (0.56) | PTGS2LPLLIPGCYP3A4ESR1 | |
| SCHEMBL868509 | 0.76 | LPL (0.40) | PTGS2LPLLIPGCYP3A4ESR1 | |
| SCHEMBL14941616 | 0.76 | LPL (0.40) | PTGS2LPLLIPGCYP3A4ESR1 | |
| SCHEMBL27949745 | 0.75 | LPL (0.45) | PTGS2LPLLIPGOPRM1 | |
| SCHEMBL9891143 | 0.75 | LPL (0.55) | PTGS2LPLLIPGCYP3A4SLC6A2 | |
| SCHEMBL2989869 | 0.72 | PTGS2 (0.36) | PTGS2LPLLIPGCYP3A4ESR1 | |
| SCHEMBL9892719 | 0.70 | LPL (0.40) | PTGS2LPLLIPGOPRM1 | |
| SCHEMBL3555634 | 0.70 | PTGS2 (0.48) | PTGS2LPLLIPGCYP3A4ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9611233-B2 | Organic compound | CANON KABUSHIKI KAISHA (JP) | 2017-04-04 | — | — | US | disclosed |
| US-20160152633-A1 | NOVEL ORGANIC COMPOUND | CANON KK (JP) | 2016-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152633-A1 | NOVEL ORGANIC COMPOUND | AOX1, AOC2, OXER1 | PTGS2 2039/4885LPL 3468/4885LIPG 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.